Benjamin Lok, MD (@benlok) 's Twitter Profile
Benjamin Lok, MD

@benlok

Physician-scientist, thoracic oncologist (radiation). DNA repair, novel therapeutics, resistance mechanisms. @pmcancercentre @RadMedPM @PMResearch_UHN @UofTDRO

ID: 17739425

linkhttps://www.uhnresearch.ca/researcher/benjamin-lok calendar_today29-11-2008 18:57:13

206 Tweet

693 Followers

394 Following

Benjamin Lok, MD (@benlok) 's Twitter Profile Photo

Thanks to Ontario Government for support of our research on how to more effectively treat small cell lung cancer - this funding will propel our work on behalf of Ontarians and beyond. 🙏

Benjamin Lok, MD (@benlok) 's Twitter Profile Photo

Proud to be a part of this cohort and to be promoted at Radiation Oncology - congrats to my fellow colleagues!🎉🎉🎉 Catherine Coolens Jennifer Croke (she/her) Alexandra Rink Danielle Rodin #TeodorStanescu Danny Vesprini and thanks to mentors, colleagues, and my family for all their support+encouragement! 🙏

iacovos michael 🇨🇦 (@iacovosmichael) 's Twitter Profile Photo

This week marks 1 year since we initiated NET tissue biobanking. Today, we received tissue samples from the 40th patient. We want to take this opportunity to express our deep gratitude to all the patients who have generously donated samples. Julie Hallet Neuroendocrine Cancer Research Foundation Terry Fox Research Institute

This week marks 1 year since we initiated NET tissue biobanking. Today, we received tissue samples from the 40th patient.
We want to take this opportunity to express our deep gratitude to all the patients who have generously donated samples.
<a href="/HalletJulie/">Julie Hallet</a> <a href="/CureNETs/">Neuroendocrine Cancer Research Foundation</a> <a href="/tfri_research/">Terry Fox Research Institute</a>
Advances, an ASTRO Journal (@advances_astro) 's Twitter Profile Photo

Welcome to Advances in Radiation Oncology's X account! Follow us here to read about the latest advances in our field and to learn about innovative scholarship emerging from our specialty! #ASTRO24

Welcome to Advances in Radiation Oncology's X account! Follow us here to read about the latest advances in our field and to learn about innovative scholarship emerging from our specialty! #ASTRO24
Advances, an ASTRO Journal (@advances_astro) 's Twitter Profile Photo

Connect with Editor-in-Chief, Rachel Jimenez, MD at the ASTRO Meter Board, happening now at the ASTRO Resource Center! Learn more about the future of the journal and how to get involved! #ASTRO24 Benjamin Lok, MD Krishan Jethwa @stevebraunstein Henning Willers, MD, FASTRO

Connect with Editor-in-Chief, <a href="/RachelJimenezMD/">Rachel Jimenez, MD</a> at the ASTRO Meter Board, happening now at the ASTRO Resource Center! Learn more about the future of the journal and how to get involved! #ASTRO24 <a href="/BenLok/">Benjamin Lok, MD</a> <a href="/KrishanJethwa/">Krishan Jethwa</a> @stevebraunstein <a href="/HenningWillers/">Henning Willers, MD, FASTRO</a>
Henning Willers, MD, FASTRO (@henningwillers) 's Twitter Profile Photo

#ASTRO24 Terrific early morning #lungcancer session🫁‼️ Benjamin Lok, MD reporting on tolerability of PARPi with IMRT as consolidation in patients with ES-SCLC🙏 Important to restrict esophagitis‼️ Excellent basis for future development of PARPi in this space👍 #LCSM

#ASTRO24
Terrific early morning #lungcancer session🫁‼️

<a href="/BenLok/">Benjamin Lok, MD</a> reporting on tolerability of PARPi with IMRT as consolidation in patients with ES-SCLC🙏

Important to restrict esophagitis‼️

Excellent basis for future development of PARPi in this space👍 #LCSM
Gerry Hanna (@gerryhanna) 's Twitter Profile Photo

Is PARPi safe with consolidative RT in ES-SCLC? 🔊Seems so Ph1 presented by Benjamin Lok, MD at #ASTRO24 of Talazoparib concurrent with RT. 👉MTD of talazoparib with RT is 1 mg 👉5% Grade 3 and 55% Grade 1-2 oesophagitis 👉No new safety signals ⏭️Future combos with IO and BiTEs

Is PARPi safe with consolidative RT in ES-SCLC? 
🔊Seems so

Ph1 presented by <a href="/BenLok/">Benjamin Lok, MD</a> at #ASTRO24 of Talazoparib concurrent with RT.

👉MTD of talazoparib with RT is 1 mg
👉5% Grade 3 and 55% Grade 1-2 oesophagitis
👉No new safety signals 

⏭️Future combos with IO and BiTEs
Princess Margaret Cancer Centre Research (@pmresearch_uhn) 's Twitter Profile Photo

🔬 New strategy to boost immunotherapy for small cell lung cancer (SCLC): Combining PARP inhibitors + radiotherapy activates immune pathways & boosts T cell-attracting chemokines, discovered by Benjamin Lok, MD’s team at University Health Network Princess Margaret Cancer Centre. Read in Nature Communications: nature.com/articles/s4146…

🔬 New strategy to boost immunotherapy for small cell lung cancer (SCLC): Combining PARP inhibitors + radiotherapy activates immune pathways &amp; boosts T cell-attracting chemokines, discovered by <a href="/BenLok/">Benjamin Lok, MD</a>’s team at <a href="/UHN/">University Health Network</a> <a href="/pmcancercentre/">Princess Margaret Cancer Centre</a>.

Read in <a href="/NatureComms/">Nature Communications</a>: nature.com/articles/s4146…
Princess Margaret Cancer Centre Research (@pmresearch_uhn) 's Twitter Profile Photo

🧬 The team also found that PRMT inhibitor could improve SCLC treatment outcomes from an epigenetic point of view: A PRMT inhibitor (MS023) disrupts splicing, increases DNA damage & shows strong synergy with chemo & radiation. Published in Neoplasia: doi.org/10.1016/j.neo.…

Princess Margaret Cancer Centre Research (@pmresearch_uhn) 's Twitter Profile Photo

A team led by Dr. Benjamin Lok, MD University Health Network has found a new target to enhance radiation therapy in small cell lung cancer. By removing the function of gene HDAC3, cancer cells became more sensitive to radiation and tumour growth was inhibited: uhnresearch.ca/news/increasin…; aacrjournals.org/mct/article/do…

A team led by Dr. <a href="/BenLok/">Benjamin Lok, MD</a> <a href="/UHN/">University Health Network</a> has found a new target to enhance radiation therapy in small cell lung cancer. By removing the function of gene HDAC3, cancer cells became more sensitive to radiation and tumour growth was inhibited:

uhnresearch.ca/news/increasin…;
aacrjournals.org/mct/article/do…
UHN Research (@uhn_research) 's Twitter Profile Photo

Researchers at Princess Margaret Cancer Centre Research have identified a potential new target to enhance radiation therapy for #SmallCellLungCancer. Blocking HDAC3 protein function makes cancer cells more sensitive to radiation. 🔗 Read more: uhnresearch.ca/news/increasin…